000 | 01916 a2200601 4500 | ||
---|---|---|---|
005 | 20250516013024.0 | ||
264 | 0 | _c20110128 | |
008 | 201101s 0 0 eng d | ||
022 | _a1423-0232 | ||
024 | 7 |
_a10.1159/000320162 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOven Ustaalioglu, Bala Basak | |
245 | 0 | 0 |
_aDoes the metastatic lymph node ratio influence the disease-free survival of patients with breast cancer: single-center experiences. _h[electronic resource] |
260 |
_bOncology _c2010 |
||
300 |
_a105-11 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 | _aAxilla |
650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
650 | 0 | 4 |
_aBreast Neoplasms _xchemistry |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInflammatory Breast Neoplasms _xmortality |
650 | 0 | 4 | _aKaplan-Meier Estimate |
650 | 0 | 4 | _aLymph Node Excision |
650 | 0 | 4 |
_aLymph Nodes _xpathology |
650 | 0 | 4 | _aLymphatic Metastasis |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNecrosis |
650 | 0 | 4 |
_aNeoadjuvant Therapy _xmethods |
650 | 0 | 4 | _aNeoplasm Invasiveness |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aProportional Hazards Models |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aRisk Factors |
700 | 1 | _aBilici, Ahmet | |
700 | 1 | _aKefeli, Umut | |
700 | 1 | _aSeker, Mesut | |
700 | 1 | _aYildirim, Emre | |
700 | 1 | _aSalepci, Taflan | |
700 | 1 | _aOncel, Mustafa | |
700 | 1 | _aKement, Metin | |
700 | 1 | _aGumus, Mahmut | |
773 | 0 |
_tOncology _gvol. 79 _gno. 1-2 _gp. 105-11 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000320162 _zAvailable from publisher's website |
999 |
_c20384880 _d20384880 |